Back

SGLT2i and GLP1ra in cardiomyopathies: present and future

28 November 2025 (17:45 - 17:55)
Organised by: Logo
Seminar Presentation Part of: SESSION VII - Diabetic Cardiomyopathy: does it exist? Pericardial Disease, Other Open Access M&PD Annual meeting 2025 WG on Myocardial and Pericardial Diseases

About the speaker

Photo
Professor Petar Seferovic

Faculty of Medicine, University of Belgrade, Belgrade (Serbia)

2 More presentations in this session

Presentation thumbnail
Yes
Professor J. Kuusisto (Kuopio, FI)
Slides
Presentation thumbnail
No
Professor S. Heymans (Maastricht, NL)
Slides

Access the full session

Session thumbnail
SESSION VII - Diabetic Cardiomyopathy: does it exist?

The Event

Event poster

M&PD Annual meeting 2025

28 November 2025 17:45 CET
You may be interested in
thumbnail
Congress Session
Diabetes, obesity, and heart failure
19 May 2025
thumbnail
Congress Presentation
Effect of SGLT2i empagliflozin on left ventricular and mitochondrial function in a porcine model of anthracycline-induced cardiotoxicity
20 May 2023
thumbnail
Congress Presentation
Sodium-glucose cotransporter 2 inhibitors in patients with transthyretin amyloid cardiomyopathy - results from a patient series
20 May 2023
thumbnail
Congress Session
Evolving treatment paradigms in heart failure: from SGLT2 inhibition to transthyretin stabilisation and beyond
20 May 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources